Patents by Inventor Sami MELKONIEMI

Sami MELKONIEMI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10827934
    Abstract: An arrangement (100) and a device (101) for determining pulse transit time comprise an accelerometer (102) and a pulse wave sensor (103) for sensing a pulse wave. The accelerometer (102) determines a cardiac systole, and the pulse wave sensor (103) determines the pulse wave induced by said cardiac systole ejection. A first trigger signal is determined at the moment of said determined cardiac systole, and a second trigger signal at the moment of said determined pulse wave. The pulse transit time is then determined as a time difference between said first and second trigger signals.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: November 10, 2020
    Assignee: Nokia Technologies Oy
    Inventors: Niku Oksala, Antti Vehkaoja, Sami Melkoniemi
  • Patent number: 10342495
    Abstract: A system for providing an early risk recognition monitoring by measurement of a peripheral tissue perfusion of a patient instead of clinically significant changes in systemic blood pressure and/or blood flow comprises a wristband device for gathering measurement data of the patient. The device measures a first temperature (t1) of the patient at the first wrist (or distal antebrachium) point and a second temperature (t2) of the patient at the second finger point, whereupon the system determines altered peripheral tissue perfusion by determining temperature gradient (?t) between said first and second points. If the gradient (?t) exceeds or deceeds a predetermined range, the system construes the exceeding as a peripheral vasoconstriction and the deceeding as a peripheral vasodilatation, and thereby provides a first early risk recognition phase (p1) and transmits it as a warning indication to end devices of health care personnel.
    Type: Grant
    Filed: May 19, 2014
    Date of Patent: July 9, 2019
    Assignee: Nokia Technologies Oy
    Inventors: Sami Melkoniemi, Stefano Campadello, Niku Oksala
  • Publication number: 20170143216
    Abstract: An arrangement (100) and a device (101) for determining pulse transit time comprise an accelerometer (102) and a pulse wave sensor (103) for sensing a pulse wave. The accelerometer (102) determines a cardiac systole, and the pulse wave sensor (103) determines the pulse wave induced by said cardiac systole ejection. A first trigger signal is determined at the moment of said determined cardiac systole, and a second trigger signal at the moment of said determined pulse wave. The pulse transit time is then determined as a time difference between said first and second trigger signals.
    Type: Application
    Filed: June 17, 2015
    Publication date: May 25, 2017
    Applicant: Nokia Technologies Oy
    Inventors: Niku OKSALA, Antti VEHKAOJA, Sami MELKONIEMI
  • Publication number: 20160120418
    Abstract: A method for measuring blood pressure of a patient continuously and non-invasively comprises measuring a first pressure signal being proportional to arterial blood pressure of the patient at a first location by a first pressure sensor (P1). In addition ambient pressure is measured by a third ambient pressure sensor (P3).
    Type: Application
    Filed: June 3, 2014
    Publication date: May 5, 2016
    Inventors: Niku Oksala, Sami Melkoniemi
  • Publication number: 20160081628
    Abstract: A system for providing an early risk recognition monitoring by measurement of a peripheral tissue perfusion of a patient instead of clinically significant changes in systemic blood pressure and/or blood flow comprises a wristband device for gathering measurement data of the patient. The device measures a first temperature (t1) of the patient at the first wrist (or distal antebrachium) point and a second temperature (t2) of the patient at the second finger point, whereupon the system determines altered peripheral tissue perfusion by determining temperature gradient (?t) between said first and second points. If the gradient (?t) exceeds or deceeds a predetermined range, the system construes the exceeding as a peripheral vasoconstriction and the deceeding as a peripheral vasodilatation, and thereby provides a first early risk recognition phase (p1) and transmits it as a warning indication to end devices of health care personnel.
    Type: Application
    Filed: May 19, 2014
    Publication date: March 24, 2016
    Inventors: Sami MELKONIEMI, Stefano CAMPADELLO, Niku OKSALA